Yajing Zhao

8PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 12, 2025
Phase II Trial of an Orelabrutinib-Based Combination Therapy in Newly Diagnosed Primary Central Nervous System Lymphoma.

Yajing Zhao, Xinguang Liu, Qiang He

|Mar 11, 2025
Effects of orelabrutinib, a BTK inhibitor, on antibody-mediated platelet destruction in primary immune thrombocytopenia.

Tian-Shu Yu, Shou-Qing Han, Ling-Jun Wang

|Dec 19, 2024
Corticosteroids plus metformin versus corticosteroids as front-line treatment for patients with newly diagnosed ITP and pre-existing type 2 diabetes mellitus: A multicentre propensity score-matched study.

Xi-Ran Hou, Zhen-Yu Yan, Shuang Liu

|Nov 26, 2021
Atorvastatin restores imbalance of cluster of differentiation 4 (CD4)+ T cells in immune thrombocytopenia in vivo and in vitro.

Pengcheng Xu, Yajing Zhao, Tianshu Yu

|Aug 02, 2021
Proteomic analysis and microRNA expression profiling of plasma-derived exosomes in primary immune thrombocytopenia.

Yunqi Sun, Yu Hou, Guiyue Meng

|May 16, 2021
Platelet autoantibody specificity and response to rhTPO treatment in patients with primary immune thrombocytopenia.

Yafei Yu, Yu Hou, Yajing Zhao

Pageof 2

Frequent Collaborators

5 joint publications

Xinguang Liu

5 joint publications

Yu Hou

2 joint publications

Ming Hou

1 joint publications

Xi-Ran Hou